|
|
|
|
|
by crakenzak
821 days ago
|
|
Yup Casgevy & Lyfgenia! These sickle cell (and now also approved for beta thalassemia) CRISPR therapies basically work in the following way: - Blood stem cells are removed from the patient and the CRISPR Cas9 protein outside of the body is injected to cut the gene responsible for suppressing fetal hemoglobin production (even people with sickle cell have healthy fetal hemoglobin, their adult hemoglobin gene is what causes the deformed red blood cells) - Chemotherapy is used to kill all living bone marrow and remove all previous unedited stem cells. - New edited stem cells are inserted, and patient recovers with new blood production being of healthy red blood cells. I'd say a huge step forward was FDA and EMA approval, but figuring out a way to remove previous unedited stem cells with chemotherapy would be a step change in the patient experience. |
|